Daxor Corporation is a medical instruments & supplies business based in the US. Daxor Corporation shares (DXR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $9.89 – an increase of 11.04% over the previous week.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $9.89 |
|---|---|
| 52-week range | $7.11 - $10.04 |
| 50-day moving average | $9.03 |
| 200-day moving average | $8.97 |
| Wall St. target price | $23.38 |
| PE ratio | 8.0036 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $1.16 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $9.2842 from 2024-11-22
| 1 week (2024-11-19) | 3.27% |
|---|---|
| 1 month (2024-10-25) | 4.26% |
| 3 months (2024-08-26) | 8.21% |
| 6 months (2024-05-24) | -2.44% |
| 1 year (2023-11-24) | 16.93% |
|---|---|
| 2 years (2022-11-25) | -5.26% |
| 3 years (2021-11-24) | 11 |
| 5 years (2019-11-26) | 9.4647 |
Valuing Daxor Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Daxor Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Daxor Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Daxor Corporation shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $154,205 |
|---|---|
| Gross profit TTM | $231,641 |
| Return on assets TTM | -1.4% |
| Return on equity TTM | 5.35% |
| Profit margin | 1094% |
| Book value | $6.75 |
| Market Capitalization | $44.9 million |
TTM: trailing 12 months
We're not expecting Daxor Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Daxor Corporation's shares have ranged in value from as little as $7.11 up to $10.04. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Daxor Corporation's is -0.541. This would suggest that Daxor Corporation's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Daxor Corporation has bucked the trend.
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.